References

  1. Bastuji-Garin S, Diepgen TL. Cutaneous malignant melanoma, sun exposure, and sunscreen use: epidemiological evidence. Br J Dermatol. 2002; 146(61):24-30. Google Scholar

  2. Erdei E, Torres S M. a new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther. 2010; 10(11):1811-1823. PubMed | Google Scholar

  3. Grange F. Épidémiologie du mélanome cutané: données descriptives en France et en Europe. Ann Dermatol Venerol. 2005. 132(12 part 1):975-82. PubMed | Google Scholar

  4. Rouhani P, Hu S, Kirsner RS. Melanoma in Hispanic and black Americans. Cancer Control. 2008; 15(3):248-253. PubMed | Google Scholar

  5. Cormier JN, Xing Y, Ding M, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med. 2006; 166(17):1907-1914. PubMed | Google Scholar

  6. Swan MC, Hudson DA. Malignant melanoma in South Africans of mixed ancestry: a retrospective analysis. Melanoma Research. 2003; 13(4):415-419. PubMed | Google Scholar

  7. El Euch D, Zaraa I, Driss M, Fourati M, Mokni M, Rahal K et al. Le mélanome en Tunisie: Etude anatomoclinique de 46 cas. Ann Dermatol Vénérol. 2010; 137(5):391-392. Google Scholar

  8. Zouhair K, El Ouazzani D, Lazrak S, Azzouzi S, Lakhdar H. Le mélanome cutané à Casablanca: à propos de 82 cas. Nouv Dermatol. 2004; 23(6):346-349. Google Scholar

  9. Desmond RA, Soong S. Epidemiology of malignant melanoma. Surg Clin Nor Am. 2003; 83(1):1-29. Google Scholar

  10. Samaila MOA, Rafindadi A H. Pattern of Cutaneous Malignant Melanoma in Zaria, Nigeria. Ann Afr Med. 2006; 5(1):16-19. PubMed | Google Scholar

  11. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM et al. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol. 2001; 19(16):3622-3634. PubMed | Google Scholar

  12. Hinz T, Ahmadzadehfar H, Wierzbicki A, Hoeller T, Wenzel J, Biersack HJ, Bieber T, Schmid-Wendtner MH. Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution. Eur J Nucl Med Mol Imaging. 2012; 39(8):1316-1325. PubMed | Google Scholar

  13. Fujisawa Y, Otsuka F, Japanese Melanoma Study Group. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (> 4mm) melanoma: multicenter, retrospective study of 291 Japanese patients. Melanoma Res. 2012; 22(5):362-367. Google Scholar

  14. Criscione V D, Weinstock M A. Melanoma Thickness Trends in the United States 1988-2006. J Invest Dermatol. 2010; 130(3):793-79. PubMed | Google Scholar

  15. Mar V, Roberts H, Wolfe R, English DR, Kelly JW. Nodular melanoma: A distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia. JAAD. 2012; S0190-9622(12)01058-4. Google Scholar

  16. Geller AC and coll. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia. Cancer. Mar 2009; 115(6):1318-27. Google Scholar

  17. Grange F. Clinical and Sociodemographic Characteristics Associated With Thick Melanomas: A Population-Based, Case-Case Study in France. Arch Dermatol. Sept 2012; 17:1-7. PubMed | Google Scholar

  18. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005; 353(20):2135-2147. Google Scholar

  19. Nagore E, Pereda C, Botella-Estrada R, Requena C, Guillen C. Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility. Cancer Causes Control. 2009; 20(1):115-1. Google Scholar

  20. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006; 24(26):4340-4346. Google Scholar

  21. Ladstein RG, Bachmann IM, Straume O, Akslen LA.Tumor Necrosis Is a Prognostic Factor in Thick Cutaneous Melanoma. Am J Surg Pathol. 2012; 36(10):1477-82. PubMed | Google Scholar

  22. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005; 353(20):2135-2147. PubMed | Google Scholar